Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-mesonephros (AGM) region prior to haematopoietic stem cell (HSC) generation. The arterial programme depends on Dll4 and the haemogenic endothelium/HSC on Jag1-mediated Notch1 signalling. How Notch1 distinguishes and executes these different programmes in response to particular ligands is poorly understood. By using two Notch1 activation trap mouse models with different sensitivity, here we show that arterial endothelial cells and HSCs originate from distinct precursors, characterized by different Notch1 signal strengths. Microarray analysis on AGM subpopulations demonstrates that the Jag1 ligand stimulates low Notch strength, inhibits the endo...
Our vascular system is an organized and hierarchical blood vessel network lined by a monolayer of en...
Abstract Notch is a critical regulator of angiogenesis and arterial specification. We show that ecto...
Multiple myeloma(MM) is an incurable plasma cells malignancy. MM is characterized by aberrant activa...
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-m...
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta–gonad–m...
The activation of Notch1 receptor triggers differential outcomes depending on the upstream activatin...
Hematopoietic stem cells (HSCs) originate from a specialized subset of arterial endothelial cells te...
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium in cluster structures that pr...
The hematopoietic stem cell (HSC) sustains blood homeostasis throughout life in vertebrates. During ...
AbstractDuring development, endothelial cells (EC) display tissue-specific attributes that are uniqu...
During development, endothelial cells (EC) display tissue-specific attributes that are unique to eac...
Endothelial sprouting and proliferation are tightly coordinated processes mediating the formation of...
Abstract Background Endothelial cells have been shown to mediate angiogenesis in ischemic injury sit...
Hemogenic endothelium (HE) undergoes endothelial-to-hematopoietic transition (EHT) to generate blood...
<div><p>Hemogenic endothelium (HE) undergoes endothelial-to-hematopoietic transition (EHT) to genera...
Our vascular system is an organized and hierarchical blood vessel network lined by a monolayer of en...
Abstract Notch is a critical regulator of angiogenesis and arterial specification. We show that ecto...
Multiple myeloma(MM) is an incurable plasma cells malignancy. MM is characterized by aberrant activa...
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-m...
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta–gonad–m...
The activation of Notch1 receptor triggers differential outcomes depending on the upstream activatin...
Hematopoietic stem cells (HSCs) originate from a specialized subset of arterial endothelial cells te...
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium in cluster structures that pr...
The hematopoietic stem cell (HSC) sustains blood homeostasis throughout life in vertebrates. During ...
AbstractDuring development, endothelial cells (EC) display tissue-specific attributes that are uniqu...
During development, endothelial cells (EC) display tissue-specific attributes that are unique to eac...
Endothelial sprouting and proliferation are tightly coordinated processes mediating the formation of...
Abstract Background Endothelial cells have been shown to mediate angiogenesis in ischemic injury sit...
Hemogenic endothelium (HE) undergoes endothelial-to-hematopoietic transition (EHT) to generate blood...
<div><p>Hemogenic endothelium (HE) undergoes endothelial-to-hematopoietic transition (EHT) to genera...
Our vascular system is an organized and hierarchical blood vessel network lined by a monolayer of en...
Abstract Notch is a critical regulator of angiogenesis and arterial specification. We show that ecto...
Multiple myeloma(MM) is an incurable plasma cells malignancy. MM is characterized by aberrant activa...